Viewing Study NCT06505395


Ignite Creation Date: 2025-12-24 @ 1:39 PM
Ignite Modification Date: 2025-12-31 @ 12:16 AM
Study NCT ID: NCT06505395
Status: RECRUITING
Last Update Posted: 2024-08-26
First Post: 2024-07-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET)
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module